The Enterprise Value as of December 2025 (TTM) for Lumosa Therapeutics Co., Ltd. (6535.TWO) is 30.44B

According to Lumosa Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 30.44B. This represents a change of -13.96% compared to the average of 35.38B of the last 4 quarters.

Lumosa Therapeutics Co., Ltd. (6535.TWO) Historical Enterprise Value (quarterly & annually)

How has 6535.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Lumosa Therapeutics Co., Ltd. over the last ten years is 8.44B. The current 30.44B Enterprise Value has changed 35.96% with respect to the historical average. Over the past ten years (40 quarters), 6535.TWO's Enterprise Value was at its highest in in the September 2024 quarter at 53.68B. The Enterprise Value was at its lowest in in the September 2017 quarter at 2.39B.

Lumosa Therapeutics Co., Ltd. (6535.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lumosa Therapeutics Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lumosa Therapeutics Co., Ltd. (6535.TWO) Average Enterprise Value

How has 6535.TWO Enterprise Value performed in the past?

The current Enterprise Value of Lumosa Therapeutics Co., Ltd. (6535.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lumosa Therapeutics Co., Ltd. (6535.TWO) Enterprise Value vs. Peers

How is 6535.TWO’s Enterprise Value compared to its peers?

Lumosa Therapeutics Co., Ltd.’s Enterprise Value is greater than Oneness Biotech Co., Ltd. (26.59B), less than Lin BioScience, Inc. (32.23B), greater than Polaris Group (26.28B), greater than Pell Bio-Med Technology Co., Ltd. (21.42B), greater than TaiMed Biologics Inc. (16.87B), greater than EirGenix Inc. (17.67B), greater than Sunmax Biotechnology Co., Ltd. (20.94B), greater than Medigen Vaccine Biologics Corporation (12.63B), greater than Tanvex BioPharma, Inc. (16.20B), greater than Caliway Biopharmaceuticals Co., Ltd. (20.63B),

Build a custom stock screener for Lumosa Therapeutics Co., Ltd. (6535.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lumosa Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lumosa Therapeutics Co., Ltd. (6535.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lumosa Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.